Key facts
- This page summarizes Douglas S. Rohrer's Form 3 filing for BLOOMIOS, INC..
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Dec 2022, 17:15.
Douglas S. Rohrer - 22 Nov 2022 Form 3 Insider Report for BLOOMIOS, INC.
- Reporting relationship
- Chief Business Officer
- Issuer ticker
- N/A
- Reported as of
- 22 Nov 2022
- Net transaction value
- $0
- Reporting owner signature
- /s/ Douglas S Rohrer
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Douglas S. Rohrer filed Form 3 for BLOOMIOS, INC. on 02 Dec 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLMS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,697
- Date
- 22 Nov 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BLMS
holding
Derivative
Stock Option Grant
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 22 Nov 2022
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 550,000
- Exercise price
- $1.69
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Common shares acquired through market trades occurring 11/22/2022 to 12/2/2022.
Footnote F2
50,000 shares exercisable on the Date of Grant of 5/4/2022; 200,000 shares on the date that the Company is approved for up-listing on Nasdaq; and the balance of 300,000 shall vest equally over 24 months commencing on the one-year anniversary of the Date of Grant and become exercisable on the 18th day of each month thereafter (and if there is no corresponding day, the last day of the month).